vericiguat
Sign in to saveVericiguat, sold under the brand name Verquvo, is a medication used to reduce the risk of cardiovascular death and hospitalization in certain patients with heart failure after a recent acute decompensation event. It is taken by mouth. Vericiguat is a soluble guanylate cyclase (sGC) stimulator.
Key facts
- Drug.image
- Vericiguat Structural formula V1.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- Verquvo
- Drug.DailyMedID
- Vericiguat
- Drug.pregnancy_AU
- D
- Drug.pregnancy_category
- Contraindicated
- Drug.routes_of_administration
- By mouth
- Drug.class
- Soluble guanylate cyclase activator
- Drug.ATC_prefix
- C01
- Drug.ATC_suffix
- DX22
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.CAS_number
- 1350653-20-1
- Drug.PubChem
- 54674461
- Drug.DrugBank
- DB15456
- Drug.ChemSpiderID
- 32700337
via Wikipedia infobox
Chemical data
- Formula
- C19H16F2N8O2
- Molecular weight
- 426.4 g/mol
- IUPAC name
- methyl N-[4,6-diamino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- +426.136
Show 1 more fact
- P3493
- boxed warning
via Wikidata · CC0
Article
10 sectionsContents
- Medical uses
- Adverse effects
- Pharmacology
- Pharmacokinetics
- History
- Society and culture
- Legal status
- References
- Further reading
- External links
Vericiguat, sold under the brand name Verquvo, is a medication used to reduce the risk of cardiovascular death and hospitalization in certain patients with heart failure after a recent acute decompensation event. It is taken by mouth. Vericiguat is a soluble guanylate cyclase (sGC) stimulator.
Common side effects include low blood pressure and low red cell count (anemia).